Hai Tran

8PUBLICATIONS
119CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Jan 13, 2026
Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights.

Allison L Brodsky, Amma Asare, Bryan Fellman

|Aug 27, 2025
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC.

Federica Pecci, Hui Li, Alessandro Di Federico

|Nov 26, 2024
Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas.

Faye M Johnson, Madison P O'Hara, Lacin Yapindi

|Jul 05, 2023
EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.

Guan-Yu Xiao, Xiaochao Tan, Bertha L Rodriguez

|Jan 03, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC.

Sonia A Patel, Monique B Nilsson, Yan Yang

Pageof 2